The induction of G2/M cell-cycle arrest and apoptosis by cucurbitacin E is associated with increased phosphorylation of eIF2α in leukemia cells
Authors:
- Enlong MaEMEnlong Ma
- Xiaolong WangXWXiaolong Wang
- Jinfang XiaoJXJinfang Xiao
- Yongkui JingYJYongkui Jing
- 1 April 2010
- journal article
- case report
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 21 (4) , 389-400
Abstract
The antiproliferative and apoptotic effects of cucurbitacin E, a natural product isolated from Cucurbitaceae, were determined in human leukemia HL-60 cells. Cucurbitacin E at low concentrations (3–50 nmol/l) inhibited the growth of HL-60 cells, which was associated with G2/M cell-cycle arrest, decrease in the levels of cyclin-dependent kinase1, and increase in the levels of p21waf1. Cucurbitacin E at high concentrations (1–10 mol/l) induced apoptosis of HL-60 cells and activation of caspase-3, caspase-8, and caspase-9. Jurkat leukemia cells with or without caspase-8 expression were nearly equally sensitive to cucurbitacin E-induced apoptosis. Cucurbitacin E did not increase the levels of reactive oxygen species and antioxidants, N-acetylcysteine and catalase, did not block cucurbitacin E-induced apoptosis. Cucurbitacin E decreased the levels of the antiapoptotic proteins XIAP, survivin, and Mcl-1, but increased the level of the proapoptotic protein, Bax. The levels of phosphorylated eukaryotic translation initiation factor 2 subunit (eIF2) were induced in cells undergoing both apoptosis and cell-cycle arrest. As phosphorylated eIF2 is an inhibitor of protein translation initiation, our data suggest that cucurbitacin E induces cell growth arrest and apoptosis through the induction of eIF2 phosphorylation, which leads to the inhibition of cyclin-dependent kinase 1, Mcl-1, survivin, and/or XIAP protein synthesis and that cucurbitacin E induces apoptosis mainly through a mitochondrial-mediated pathway.Keywords
This publication has 39 references indexed in Scilit:
- Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cellsLeukemia Research, 2008
- Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivoCancer Science, 2008
- JSI-124 inhibits glioblastoma multiforme cell proliferation through G2/M cell cycle arrest and apoptosis augmentationCancer Biology & Therapy, 2008
- Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: The role of p53 and p21Biochemical Pharmacology, 2008
- Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiformeInternational Journal of Cancer, 2008
- Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin BCancer Chemotherapy and Pharmacology, 2008
- Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancerEuropean Journal of Pharmacology, 2008
- Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinomaEuropean Archives of Oto-Rhino-Laryngology, 2008
- Cucurbitacins and cucurbitane glycosides: structures and biological activitiesNatural Product Reports, 2005
- Cucurbitacins as Constituents ofWilbrandia ebracteataPlanta Medica, 1993